SOUTH
SAN FRANCISCO, California and VANCOUVER, Canada, March 8,
2023 /CNW/ - ESSA Pharma Inc. ("ESSA", or the
"Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company
focused on developing novel therapies for the treatment of prostate
cancer, today announced that the Company will be presenting at the
virtual Oppenheimer 33rd Annual Healthcare Conference on
Wednesday, March 15, 2023, at
11:20 a.m. Eastern Time.
David R. Parkinson, President and
Chief Executive Officer of ESSA Pharma; Peter Virsik, ESSA's Chief Operating Officer;
and David S. Wood, ESSA's Chief
Financial Officer, will host and participate in one-on-one
meetings.
A live webcast of the Oppenheimer presentation can be accessed
in the Investors/Events & Presentations section of ESSA's
website at www.essapharma.com. Following the event, the webcast
will be archived on the ESSA website for 90 days.
About ESSA Pharma Inc.
ESSA is a clinical-stage pharmaceutical company focused on
developing novel and proprietary therapies for the treatment of
patients with prostate cancer. For more information, please visit
www.essapharma.com and follow us on Twitter under @ESSAPharma.
View original
content:https://www.prnewswire.com/news-releases/essa-pharma-to-present-at-the-oppenheimer-33rd-annual-healthcare-conference-301765119.html
SOURCE ESSA Pharma Inc